Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 1
1972 3
1973 2
1974 2
1975 1
1976 2
1979 8
1980 4
1981 9
1982 6
1983 7
1984 8
1985 7
1986 3
1987 7
1988 3
1989 9
1990 10
1991 12
1992 18
1993 10
1994 21
1995 12
1996 8
1997 9
1998 6
1999 7
2000 12
2001 15
2002 6
2003 7
2004 7
2005 9
2006 7
2007 3
2008 9
2009 5
2010 5
2011 5
2012 4
2013 1
2015 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.
Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. Hébert PC, et al. Among authors: blajchman ma. N Engl J Med. 1999 Feb 11;340(6):409-17. doi: 10.1056/NEJM199902113400601. N Engl J Med. 1999. PMID: 9971864 Free article. Clinical Trial.
Defining transfusion medicine.
Blajchman MA. Blajchman MA. Transfus Med Rev. 1990 Jul;4(3):169. doi: 10.1016/s0887-7963(90)70262-3. Transfus Med Rev. 1990. PMID: 2134628 No abstract available.
The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants.
Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, Peliowski A, Rios A, LaCorte M, Connelly R, Barrington K, Roberts RS. Kirpalani H, et al. Among authors: blajchman ma. J Pediatr. 2006 Sep;149(3):301-307. doi: 10.1016/j.jpeds.2006.05.011. J Pediatr. 2006. PMID: 16939737 Clinical Trial.
Prostaglandin I2 (prostacyclin).
Kelton JG, Blajchman MA. Kelton JG, et al. Among authors: blajchman ma. Can Med Assoc J. 1980 Jan 26;122(2):175-9. Can Med Assoc J. 1980. PMID: 6988063 Free PMC article. Review.
Platelet transfusions.
Kelton JG, Blajchman MA. Kelton JG, et al. Among authors: blajchman ma. Can Med Assoc J. 1979 Nov 17;121(10):1353-8. Can Med Assoc J. 1979. PMID: 391376 Free PMC article. Review.
Rifampicin-induced immune thrombocytopenia.
Blajchman MA, Lowry RC, Pettit JE, Stradling P. Blajchman MA, et al. Br Med J. 1970 Jul 4;3(5713):24-6. doi: 10.1136/bmj.3.5713.24. Br Med J. 1970. PMID: 5427483 Free PMC article.
Substitutes for success.
Blajchman MA. Blajchman MA. Nat Med. 1999 Jan;5(1):17-8. doi: 10.1038/4694. Nat Med. 1999. PMID: 9883829 No abstract available.
Platelet substitutes.
Blajchman MA. Blajchman MA. Vox Sang. 2000;78 Suppl 2:183-6. Vox Sang. 2000. PMID: 10938949 Review.
Why implement universal leukoreduction?
Bassuni WY, Blajchman MA, Al-Moshary MA. Bassuni WY, et al. Among authors: blajchman ma. Hematol Oncol Stem Cell Ther. 2008 Apr-Jun;1(2):106-23. doi: 10.1016/s1658-3876(08)50042-2. Hematol Oncol Stem Cell Ther. 2008. PMID: 20063539 Free article. Review.
Immunomodulation and blood transfusion.
Blajchman MA. Blajchman MA. Am J Ther. 2002 Sep-Oct;9(5):389-95. doi: 10.1097/00045391-200209000-00005. Am J Ther. 2002. PMID: 12237730 Review.
290 results